Business Description
Modalis Therapeutics Corp
ISIN : JP3922600006
Share Class Description:
TSE:4883: Ordinary SharesCompare
Compare
Traded in other countries / regions
4883.Japan IPO Date
2020-08-03Description
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.57 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -74.5 | |||||
| 3-Year EPS without NRI Growth Rate | -64.9 | |||||
| 3-Year FCF Growth Rate | -17.4 | |||||
| 3-Year Book Growth Rate | -42.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.23 | |||||
| 9-Day RSI | 38.14 | |||||
| 14-Day RSI | 35.23 | |||||
| 6-1 Month Momentum % | -32.09 | |||||
| 12-1 Month Momentum % | -63.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.88 | |||||
| Quick Ratio | 9.84 | |||||
| Cash Ratio | 9.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -104.11 | |||||
| ROA % | -91.36 | |||||
| ROIC % | -1062.83 | |||||
| ROC (Joel Greenblatt) % | -1203.22 | |||||
| ROCE % | -98.52 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.91 | |||||
| Price-to-Tangible-Book | 1.91 | |||||
| EV-to-EBIT | -0.5 | |||||
| EV-to-EBITDA | -0.5 | |||||
| EV-to-FCF | -0.49 | |||||
| Price-to-Net-Current-Asset-Value | 2.01 | |||||
| Price-to-Net-Cash | 2.13 | |||||
| Earnings Yield (Greenblatt) % | -200.78 | |||||
| FCF Yield % | -85.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Modalis Therapeutics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -77.24 | ||
| Beta | 1.01 | ||
| Volatility % | 33.18 | ||
| 14-Day RSI | 35.23 | ||
| 14-Day ATR (円) | 3.60176 | ||
| 20-Day SMA (円) | 83.3 | ||
| 12-1 Month Momentum % | -63.16 | ||
| 52-Week Range (円) | 76 - 336 | ||
| Shares Outstanding (Mil) | 33.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Modalis Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Modalis Therapeutics Corp Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Modalis Therapeutics Corp Frequently Asked Questions
What is Modalis Therapeutics Corp(TSE:4883)'s stock price today?
The current price of TSE:4883 is 円79.00. The 52 week high of TSE:4883 is 円336.00 and 52 week low is 円76.00.
When is next earnings date of Modalis Therapeutics Corp(TSE:4883)?
The next earnings date of Modalis Therapeutics Corp(TSE:4883) is .
Does Modalis Therapeutics Corp(TSE:4883) pay dividends? If so, how much?
Modalis Therapeutics Corp(TSE:4883) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers